Clinical Trial Update: Microbiota Intervention to Change the Response of Parkinson's Disease [Phase 1, Phase 2]

View source ↗

Summary

The document reports that a UCSF-led Phase 1/Phase 2 clinical trial investigating a microbiota-based intervention for Parkinson's disease is currently suspended…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Microbiota intervention (unspecified)

Snippet

Sponsor: University of California, San Francisco | Conditions: Parkinson Disease | Phase 1, Phase 2 | Status: SUSPENDED